Clinical Trials on Bacterial Peritonitis in Peru

Total 110 results

Brigham and Women's Hospital
Socios En Salud Sucursal, Peru; Hospital Nacional Arzobispo Loayza; Hospital... and other collaborators

Unknown

Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission (FAST)

Tuberculosis

Peru
Brigham and Women's Hospital
National Institute of Allergy and Infectious Diseases (NIAID); Bill and Melinda... and other collaborators

Completed

Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru

Tuberculosis, Multidrug-Resistant

Peru
Universidad Peruana Cayetano Heredia

Completed

Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old

Tuberculosis | Pediatric ALL | Behavior, Health

Peru
University of California, Los Angeles
National Institute of Mental Health (NIMH); Asociación Civil Impacta Salud...

Completed

Expedited Partner Therapy for MSM in Peru

Chlamydia | Gonorrhea

Peru
Southwest Oncology Group
University of Michigan; Hope Foundation

Completed

S1119 Peruvian H. Pylori Water Contamination Study

Helicobacter Pylori Infection

Peru
Harvard University Faculty of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); Brigham and... and other collaborators

Unknown

Epidemiology of MDR-TB in Peru (Estudio Epi)

TB Multi-drug Resistant

Peru
University of California, Los Angeles
Emory University; University of California, San Francisco; Asociacion Civil Via...

Active, not recruiting

Expedited Partner Therapy and the HIV Prevention Cascade (EPT and MSM)

Chlamydia | HIV-1-infection | Partner Communication | Gonorrhea Male

Peru
Embil Pharmaceutical Co. Ltd

Terminated

Prevention of Persistence of Bacterial Vaginosis

Bacterial Vaginosis

Peru
University of California, Los Angeles
University of California, San Francisco; NGO Via Libre

Completed

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

HIV Infections | Gonorrhoea of Rectum | Chlamydia of Rectum

Peru
National Institute of Allergy and Infectious Diseases...

Completed

Diagnosing Tuberculosis in HIV Infected Children in Peru

HIV Infections | Tuberculosis | Tuberculosis, Pulmonary

Peru
Lena Shah
McGill University; Canadian Institutes of Health Research (CIHR); Universidad...

Unknown

Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program

Tuberculosis

Peru
Foundation for Innovative New Diagnostics, Switzerland
Universidad Peruana Cayetano Heredia; Kenya Medical Research Institute; V. N.... and other collaborators

Active, not recruiting

Bioneer IRONqPCR ™ RFIA Kit Kit Clinical Evaluation

Tuberculosis, Multidrug-Resistant

Kenya, Peru, Ukraine
Boston University
National Institute of Allergy and Infectious Diseases (NIAID); Centers for... and other collaborators

Completed

Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (Opti-Q)

Tuberculosis, Multidrug-Resistant

South Africa, Peru
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru
Harvard Medical School (HMS and HSDM)
National Institute of Allergy and Infectious Diseases (NIAID); Partners in... and other collaborators

Recruiting

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens (STEM-TB)

HIV | Tuberculosis, Multidrug-Resistant

Kazakhstan, Lesotho, Peru
University Hospital Inselspital, Berne
Instituto de Cardiología Paredes-Horna, Arequipa; Hospital Nacional Carlos...

Completed

Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren

Rheumatic Heart Disease | Acute Rheumatic Fever

Peru, Switzerland
Foundation for Innovative New Diagnostics, Switzerland

Completed

Prospective Assessment of TBDx Feasibility

Pulmonary Tuberculosis

Vietnam, Peru
Harvard University Faculty of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); Sanofi; University... and other collaborators

Completed

Trial of High-Dose Rifampin in Patients With TB (HIRIF)

Tuberculosis

United States, Peru, United Kingdom
National Institute of Allergy and Infectious Diseases...
Comprehensive International Program of Research on AIDS

Completed

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

HIV Infections | Sexually Transmitted Diseases | Syphilis

Ecuador, Peru
Sanofi Pasteur, a Sanofi Company

Completed

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru, Mexico
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis

HIV Infections | Tuberculosis

Peru, South Africa
Thallion Pharmaceuticals
LFB Biotechnologies, SAS

Completed

Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

Shiga Toxin Producing Bacterial Infection

Argentina, Peru, Chile
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Tuberculosis, Multidrug-Resistant

Korea, Republic of, China, Estonia, Latvia, Peru, Philippines
St George's, University of London
London School of Hygiene and Tropical Medicine; University of Botswana

Completed

A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis (RIFASHORT)

Pulmonary Tuberculosis

Botswana, Guinea, Nepal, Pakistan, Peru, Uganda
Latin American Cooperative Onco-Haematology Group...

Unknown

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Mycosis Fungoides | Sezary Syndrome

Peru
University of Cape Town
Institute of Tropical Medicine, Belgium; Epicentre; Medecins Sans Frontieres,... and other collaborators

Recruiting

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis (PandrTB)

Multi-drug Resistant Tuberculosis

Vietnam, Kazakhstan, Lesotho, Pakistan, Peru, South Africa
Médecins Sans Frontières, France
Harvard Medical School (HMS and HSDM); Institute of Tropical Medicine, Belgium and other collaborators

Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB)

Tuberculosis, Multidrug-Resistant | Infection, Bacterial | Pulmonary Tuberculoses

Pakistan, Georgia, India, Kazakhstan, Lesotho, Peru, South Africa
Universitas Padjadjaran
London School of Hygiene and Tropical Medicine; Radboud University Medical... and other collaborators

Completed

Pulmonary Tuberculosis Patients With Diabetes Mellitus (TANDEM)

Diabetes Mellitus | Pulmonary Tuberculosis

Indonesia, Peru, Romania
Inje University
Ministry of Science and ICT

Recruiting

Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)

Latent Tuberculosis | Tuberculosis | Nontuberculous Mycobacterium Infection

Korea, Republic of, Indonesia
International Union Against Tuberculosis and Lung...
United States Agency for International Development (USAID)

Unknown

Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

Tuberculosis

Algeria, Bolivia, Colombia, Guinea, Mozambique, Nepal, Peru, Tanzania, Vietnam
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

HIV Infection | Tuberculosis

Peru, Brazil, South Africa, Haiti, Kenya
University of Washington
University of Maryland, Baltimore; Bill and Melinda Gates Foundation; Aga Khan... and other collaborators

Recruiting

Enterics for Global Health (EFGH) (EFGH)

Diarrhea | Child | Shigella

Bangladesh, Gambia, Kenya, Malawi, Mali, Pakistan, Peru
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) (PNEU-WAY)

Pneumococcal Infections

United States, France, Peru, South Africa, Thailand
Janssen Infectious Diseases BVBA

Completed

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Tuberculosis

South Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID); National Institute...

Completed

Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals

HIV Infections | Tuberculosis

Peru, South Africa, Botswana, Brazil, India, Malawi, Zimbabwe
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Meningitis | Meningococcal Infection

Russian Federation, India
GlaxoSmithKline

Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Impetigo

India, Mexico, Netherlands, Italy, Peru
Partners in Health
Harvard Medical School (HMS and HSDM); Epicentre; Interactive Research and Development and other collaborators

Completed

Expand New Drugs for TB [endTB]

Tuberculosis, Multidrug-Resistant

Georgia, Armenia, Bangladesh, Belarus, Ethiopia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Myanmar, Pakistan, Peru, South Africa
GlaxoSmithKline

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Russian Federation
GlaxoSmithKline

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Russian Federation
Médecins Sans Frontières, France
Harvard Medical School (HMS and HSDM); Institute of Tropical Medicine, Belgium and other collaborators

Active, not recruiting

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (endTB-Q)

Bacterial Infections | Gram-Positive Bacterial Infections | Tuberculosis | Tuberculosis, Multidrug-Resistant | Pulmonary Tuberculoses | Mycobacterial Infections

Vietnam, Pakistan, India, Kazakhstan, Lesotho, Peru
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico (MET33)

Healthy Volunteers (Meningococcal Infection)

Mexico, Russian Federation
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis

Multidrug-resistant Tuberculosis

South Africa, Estonia, Philippines, Peru, Lithuania, Latvia, Moldova, Republic of
National Institute of Allergy and Infectious Diseases...

Recruiting

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Tuberculous Meningitis

South Africa, Zimbabwe, India, Kenya, Malawi, Mexico, Peru, Brazil, Philippines, Tanzania, Thailand, Vietnam
SPP Pharmaclon Ltd.

Recruiting

A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis

Respiratory Tuberculosis

Russian Federation
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Tuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug Resistant

Korea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment (REMEMBER)

HIV Infection

Peru, Malawi, Uganda, South Africa, India, Haiti, Zambia, Zimbabwe, Brazil, Kenya
Janssen Infectious Diseases BVBA

Completed

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Tuberculosis

China, Ukraine, Korea, Republic of, Peru, Estonia, Kenya, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (STRIDE)

HIV Infection | Tuberculosis

United States, Peru, Kenya, Malawi, Uganda, Brazil, South Africa, Zimbabwe, India, Thailand, Botswana, Haiti, Zambia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Meningitis, Meningococcal

Korea, Republic of, Mexico, Russian Federation, Thailand

Clinical Trials on Bacterial Peritonitis in Peru

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations